Advancing Transcranial Magnetic Stimulation Methods for Complex Regional Pain Syndrome: An Open‐Label Study of Paired Theta Burst and High‐Frequency Stimulation

Introduction Complex Regional Pain Syndrome (CRPS), a rare and severe chronic pain condition, often responds poorly to existing treatments. Previous studies demonstrated Transcranial Magnetic Stimulation (TMS) provided short‐term pain relief for upper extremity CRPS. Methods Building on previous met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromodulation (Malden, Mass.) Mass.), 2018-06, Vol.21 (4), p.409-416
Hauptverfasser: Gaertner, Mark, Kong, Jiang‐Ti, Scherrer, Kristen H., Foote, Alyssa, Mackey, Sean, Johnson, Kevin A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Complex Regional Pain Syndrome (CRPS), a rare and severe chronic pain condition, often responds poorly to existing treatments. Previous studies demonstrated Transcranial Magnetic Stimulation (TMS) provided short‐term pain relief for upper extremity CRPS. Methods Building on previous methodologies, we employed a TMS protocol that may lead to significant pain relief for upper and lower extremity CRPS in a nonrandomized open label pilot trial involving 21 participants. We individualized TMS coil positioning over motor cortex of somatic pain location, and administered intermittent theta‐burst stimulation followed by 10 Hz high‐frequency stimulation using a deeper targeting coil. We assessed response (≥30% pain reduction) from a single session (n = 5) and five consecutive daily sessions (n = 12) and compared change in pain from baseline, after one treatment and one‐week posttreatment between groups using a mixed ANVOA. Results Both groups demonstrated significant pain reduction after one session and one‐week posttreatment; however, no group differences were present. From a single session, 60% of participants responded at Week 1. From five sessions, 58% and 50% of participants responded at Weeks 1 and 2, respectively. Two from each group achieved >50% pain reduction beyond six to eight weeks. No serious adverse events occurred. Though headache and nausea were the most common side‐effects, we urge careful monitoring to prevent seizures with this protocol. Conclusions We used a TMS protocol that, for the first time, led to significant pain relief in upper and lower extremity CRPS, and will soon examine our protocol in a larger, controlled trial.
ISSN:1094-7159
1525-1403
DOI:10.1111/ner.12760